CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Iloprost

伊洛前列素 杂质对照品Iloprost Impurities

28 个杂质条目28 impurity entries

本页汇总 伊洛前列素 的 28 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 28 impurity reference standards of Iloprost. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 伊洛前列素(Iloprost)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsA high performance liquid radiochromatographic assay for the simultaneous analysis of iloprost and misoprostol
    Prostaglandins · 1996 · Womack IM et al.  ·  PMID 8936581  ·  DOI
  2. 分析方法Analytical MethodsIloprost-induced nociception: determination of the site of anti-nociceptive action of cyclooxygenase inhibitors and the involvement of cyclooxygenase products in central mechanisms of nociception
    Methods in molecular biology (Clifton, N.J.) · 2010 · Ayoub SS, Botting RM  ·  PMID 20645177  ·  DOI
  3. 分析方法Analytical MethodsDevelopment, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprost
    Eicosanoids · 1990 · Hildebrand M et al.  ·  PMID 1700724
  4. 分析方法Analytical MethodsDetermination of iloprost in 5% dextrose in water solution by reversed-phase high performance liquid chromatography
    Journal of pharmaceutical sciences · 1990 · Scypinski S et al.  ·  PMID 1704063  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisInhibition of ADP-ribosyltransferase increases synthesis of Gs alpha in neuroblastoma x glioma hybrid cells and reverses iloprost-dependent heterologous loss of fluoride-sensitive adenylate cyclase
    Biochemical pharmacology · 1995 · Donnelly LE et al.  ·  PMID 7535529  ·  DOI

伊洛前列素 —— 原料药与杂质对照品Iloprost — drug substance & impurities

共 29 个条目(含原料药本体)29 items incl. the drug substance
Iloprost structure
原料药 APIAPI
伊洛前列素Iloprost
Iloprost
CAS No.78919-13-8
Chemical FormulaC22H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost-d4A structure
—
伊洛前列素-d4AIloprost-d4A
Iloprost-d4A
CAS No.1035094-10-0
Chemical FormulaC22H28D4O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 1 structure
1
伊洛前列素杂质1Iloprost Impurity 1
Iloprost Impurity 1
CAS No.32233-40-2
Chemical FormulaC8H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 2 structure
2
伊洛前列素杂质2Iloprost Impurity 2
Iloprost Impurity 2
CAS No.910916-95-9
Chemical FormulaC28H48O4Si
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 3 structure
3
伊洛前列素杂质3Iloprost Impurity 3
Iloprost Impurity 3
CAS No.116896-29-8
Chemical FormulaC28H46O4Si
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 4 structure
4
伊洛前列素杂质4Iloprost Impurity 4
Iloprost Impurity 4
CAS No.116855-81-3
Chemical FormulaC28H45NO5Si
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 6 structure
6
伊洛前列素杂质6Iloprost Impurity 6
Iloprost Impurity 6
CAS No.127708-13-8
Chemical FormulaC21H38O5Si
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 7 structure
7
伊洛前列素杂质7Iloprost Impurity 7
Iloprost Impurity 7
CAS No.70073-58-4
Chemical FormulaC10H17O4P
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 8 structure
8
伊洛前列素杂质8Iloprost Impurity 8
Iloprost Impurity 8
CAS No.92007-37-9
Chemical FormulaC13H20O3
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 9 structure
9
伊洛前列素杂质9Iloprost Impurity 9
Iloprost Impurity 9
CAS No.118375-00-1
Chemical FormulaC15H24O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 10 structure
10
伊洛前列素杂质10Iloprost Impurity 10
Iloprost Impurity 10
CAS No.118374-99-5
Chemical FormulaC15H22O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 12 structure
12
伊洛前列素杂质12Iloprost Impurity 12
Iloprost Impurity 12
CAS No.74843-13-3
Chemical FormulaC22H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 13 structure
13
伊洛前列素杂质13Iloprost Impurity 13
Iloprost Impurity 13
CAS No.74843-14-4
Chemical FormulaC22H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 16 structure
16
伊洛前列素杂质16Iloprost Impurity 16
Iloprost Impurity 16
CAS No.39746-00-4
Chemical FormulaC15H16O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 17 structure
17
伊洛前列素杂质17Iloprost Impurity 17
Iloprost Impurity 17
CAS No.65025-94-7
Chemical FormulaC14H26O4Si
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 18 structure
18
伊洛前列素杂质18Iloprost Impurity 18
Iloprost Impurity 18
CAS No.64982-34-9
Chemical FormulaC21H30O5Si
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 19 structure
19
伊洛前列素杂质19Iloprost Impurity 19
Iloprost Impurity 19
CAS No.39746-01-5
Chemical FormulaC15H14O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 20 structure
20
伊洛前列素杂质20Iloprost Impurity 20
Iloprost Impurity 20
CAS No.194141-94-1
Chemical FormulaC18H18O6
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 22 structure
22
伊洛前列素杂质22Iloprost Impurity 22
Iloprost Impurity 22
CAS No.618387-07-8
Chemical FormulaC16H16O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 23 structure
23
伊洛前列素杂质23Iloprost Impurity 23
Iloprost Impurity 23
CAS No.40834-86-4
Chemical FormulaC22H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 32 structure
32
伊洛前列素杂质32Iloprost Impurity 32
Iloprost Impurity 32
CAS No.1056034-74-2
Chemical FormulaC23H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 36 structure
36
伊洛前列素杂质36Iloprost Impurity 36
Iloprost Impurity 36
CAS No.1056034-75-3
Chemical FormulaC23H32O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 37 structure
37
伊洛前列素杂质37Iloprost Impurity 37
Iloprost Impurity 37
CAS No.88295-06-1
Chemical FormulaC10H17O4P
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 38 structure
38
伊洛前列素杂质38Iloprost Impurity 38
Iloprost Impurity 38
CAS No.88295-05-0
Chemical FormulaC10H17O4P
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 40 ((Z)-Iloprost) structure
40
伊洛前列素杂质40 (Z-伊洛前列素)Iloprost Impurity 40 ((Z)-Iloprost)
Iloprost Impurity 40 ((Z)-Iloprost)
CAS No.82889-99-4
Chemical FormulaC22H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 41 (Iloprost 11-iloprost ester) structure
41
伊洛前列素杂质41 (伊洛前列素11-伊洛前列素酯)Iloprost Impurity 41 (Iloprost 11-iloprost ester)
Iloprost Impurity 41 (Iloprost 11-iloprost ester)
CAS No.126436-98-4
Chemical FormulaC44H62O7
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 42 (Iloprost 15-iloprost ester) structure
42
伊洛前列素杂质42 (伊洛前列素15-伊洛前列素酯)Iloprost Impurity 42 (Iloprost 15-iloprost ester)
Iloprost Impurity 42 (Iloprost 15-iloprost ester)
CAS No.126436-97-3
Chemical FormulaC44H62O7
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 43 (15β-Hydroxyiloprost) structure
43
伊洛前列素杂质43 (15β-羟基伊洛前列素)Iloprost Impurity 43 (15β-Hydroxyiloprost)
Iloprost Impurity 43 (15β-Hydroxyiloprost)
CAS No.85026-51-3
Chemical FormulaC22H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloprost Impurity 44 structure
44
伊洛前列素杂质44Iloprost Impurity 44
Iloprost Impurity 44
CAS No.155326-57-1
Chemical FormulaC22H30O4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

伊洛前列素 —— 研究文献与合成路线Iloprost — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 伊洛前列素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Iloprost. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Combined thrombolytic effects of tissue-plasminogen activator and a fibrinogen-degradation product peptide 6A or iloprost
    Nichols WW, Nicolini FA, Saldeen TG, et al. · Journal of cardiovascular pharmacology · 1991 · 被引 3cited 3

合成路线文献Synthetic-route papers

  1. Iloprost Attenuates Oxidative Stress-Dependent Activation of Collagen Synthesis Induced by Sera from Scleroderma Patients in Human Pulmonary Microvascular Endothelial Cells
    Giordo R, Thuan DTB, Posadino AM, et al. · Molecules (Basel, Switzerland) · 2021
  2. Influence of Iloprost on insulin synthesis in isolated human islets of Langerhans
    Löhde E, Lück M, Raude H, et al. · Transplantation proceedings · 1991
  3. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells
    Hiroi T, Maruyama K, Hattori K, et al. · Japanese journal of pharmacology · 1997

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

伊洛前列素 杂质谱研究要点Iloprost — impurity profiling notes

下面这些是拿到 伊洛前列素 的 29 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 29 impurity entries for Iloprost, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances